Altesa Funding: $79M Raised, Series B (2026)

Altesa funding overview

Altesa is based in College Park, GA. Altesa has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2026. The round record for Altesa runs through 2026; nothing later has been disclosed. Investors on record include Forbion, Sanofi, Medicxi, Pitango Venture Capital, Atlantic Partners, Sanofi-Cathay Healthcare Innovation Fund and 1 others. 7 distinct backers are named across the disclosed rounds.

Altesa at a glance

Total raised: $79M
Latest round: Series B
Latest round date: February 2026
Headquarters: College Park, GA
Notable investors: Forbion, Sanofi, Medicxi, Pitango Venture Capital, Atlantic Partners, Sanofi-Cathay Healthcare Innovation Fund, GSK

Frequently asked about Altesa funding

How much has Altesa raised?: Altesa has raised $79M in total disclosed funding across the rounds on record.
Who has invested in Altesa?: Forbion, Sanofi, Medicxi, Pitango Venture Capital, Atlantic Partners, Sanofi-Cathay Healthcare Innovation Fund are named among the investors backing Altesa.
What was the latest Altesa funding round?: The most recent disclosed round is a Series B, announced in February 2026.
Where is Altesa based?: Altesa is based in College Park, GA.
When did Altesa last raise?: The last disclosed Altesa round closed in February 2026 at Series B.

Round data for Altesa is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in College Park and backer lists below.

Altesa Funding: $79M Raised, Series B (2026)

Altesa funding overview

Altesa at a glance

Frequently asked about Altesa funding

Companies related to Altesa (18)

Browse related funding lists (7)